Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|October 7, 2009
Polyamine transport as a target for treatment of Pneumocystis pneumoniaChung-Ping Liao, Otto Phanstiel, Mark E Lasbury, et al.
Gastroenterology|February 1, 1978
Characterization and development of cimetidine as a histamine H2-receptor antagonistR W Brimblecombe, W A Duncan, G J Durant, et al.
Pathologie-Biologie|December 1, 1991
[Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers]H Etesse-Carsenti, R Garraffo, E Bernard, et al.
Antiviral Therapy|June 10, 2000
Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-upP Clevenbergh, J Durant, P Halfon, et al.
Journal of Medicinal Chemistry|July 1, 1977
Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidineG J Durant, J C Emmett, C R Ganellin, et al.
Clinical and Diagnostic Laboratory Immunology|February 10, 1998
Antibody to Pneumocystis carinii protects rats and mice from developing pneumoniaM S Bartlett, W C Angus, M M Shaw, et al.
HIV Clinical Trials|December 26, 2002
Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavirS Chaillou, J Durant, R Garraffo, et al.
BMC Microbiology|April 10, 2010
Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophagesBi-Hua Cheng, Yunlong Liu, Xiaoling Xuei, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
High prevalence of GB virus C/hepatitis G virus infection in different risk groups of HIV-infected patientsP. Clevenberg, J. Durant, P. Halfon, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 1, 2012
Efficacy and safety of Buxus sempervirens L. preparations (SPV(30)) in HIV-infected asymptomatic patients: a multicentre, randomized, double-blind, placebo-controlled trialJ Durant, P Chantre, G Gonzalez, et al.
Pageof 16